Recommendation Report slide image

Recommendation Report

. ● ● ● Hamilton Lane The General Partner is in the process of becoming a signatory to PRI and maintains a formal ESG policy, which it incorporates into its investment due diligence process and actively promotes DEI in its company culture The General Partner performs ESG diligence in the screening of its investment opportunities and consults Malk Partners, a third-party ESG firm, for advisory in its due diligence process ● Georgian ran its first annual portfolio-wide ESG survey to identify areas of opportunity and risks in 2020 Georgian focuses on diversity within its organization and has implemented initiatives to increase diversity in its own candidate pool for incoming professionals as well as on the management teams of its portfolio companies Georgian places an emphasis on its diversity and employee engagement & retention The General Partner plans to donate 1% of carry and 1% of management fees to select charities ESG Summary ESG Policy ESG-Dedicated Professionals Signatories Environmental Focus Diversity ESG in Due Diligence Process Yes Announcing a Head of ESG in the near term In the process of becoming a signatory to PRI None Environmental, Social & Governance 46% female/54% male 66% minority in decision making 66% minority in ownership Proactively identify candidates with diverse backgrounds Third party ESG DD for all investments; ESG DD policy December 2021 | Proprietary and Confidential Integration in Decision Making ESG Focus Planning Monitoring Reporting Requirements of Portfolio Companies ESG risks and opportunities considered in decision- making ESG is always included in strategic planning Monitors and collects ESG and DEI KPIs across portfolio companies Annual ESG report The GP does not require all portfolio companies to adopt ESG policies but promotes ESG and diversity practices within portfolio companies Executive Summary | General Partner | Investment Strategy | Track Record | ESG | Appendices Georgian Growth Fund VI, LP & Georgian Alignment Fund II, LP | Page 24
View entire presentation